1 recruiting, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Surgimab: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SGM-101 in Locally Advanced and Recurrent Rectal Cancer SGM-101 - Rectal Cancer, Recurrent Rectal Cancer | Phase 2 / Phase 3 | Unknown | Leiden University Medical Center | 203 | 2019-10-22 | 2020-11-24 |
| Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer SGM-101 - Colorectal Neoplasms | Phase 3 | Recruiting | Surgimab | 300 | 2019-06-17 | 2024-04-24 |
Colorectal Neoplasms (1) · Neoplasms (1) · Rectal Neoplasms (1)
Netherlands (2) · Germany (1) · Italy (1) · United States (1)